240 likes | 398 Views
I. Overview of Eukaryotic gene regulation. Mechanisms similar to those found in bacteria-most genes controlled at the transcriptional level Much more complex than prokaryotic chromatin TFs Enhancers Activators. A. Prokaryotes vs. Eukaryotes.
E N D
I. Overview of Eukaryotic gene regulation • Mechanisms similar to those found in bacteria-most genes controlled at the transcriptional level • Much more complex than prokaryotic • chromatin • TFs • Enhancers • Activators
A. Prokaryotes vs. Eukaryotes • In eukaryotes, one mRNA = one protein. (in bacteria, one mRNA can be polycistronic, or code for several proteins). • DNA in eukaryotes forms a stable, compacted complex with histones. In bacteria, the chromatin is not in a permanently condensed state. • Eukaryotic DNA contains large regions of repetitiveDNA, whilst bacterial DNA rarely contains any "extra" DNA. • Eukaryotic genes are divided into exons and introns; in bacteria, genes are almost never divided. • In eukaryotes, mRNA is synthesized in the nucleus and then processed and exported to the cytoplasm; in bacteria, transcription and translation can take place simultaneously off the same piece of DNA.
B. Eukaryote gene expression is regulated at 6 levels: Transcription RNA processing mRNA transport mRNA translation mRNA degradation Protein degradation
II. Transcriptional Control • Control factors • cis-acting “next to” elements • Promoter region: TATA box (-30), CAAT box (-80) GC box (-110) • Alternate promoters • The level of transcription initiation can vary between alternative promoters • the translation efficiency of mRNA isoforms with different leader exons can differ • alternative promoters can have different tissue specificity and react differently to some signals • Enhancers & Silencers far away from promoter • trans-acting “across from” factors • Transcription factors • Activators, Coactivators
Control factors continued: • DNA methylation (add methyl to C) • Occurs at 5’ position, usually in CG doublets • 5’-mCpG-3’ • Inverse relationship between degree of methylation and degree of expression • Not a general mechanism in eukaryotes • Transcriptionally active genes possess significantly lower levels of methylated DNA than inactive genes. • A gene for methylation is essential for development in mice (turning off a gene also can be important). • Methylation results in a human disease called fragile X syndrome; FMR-1 gene is silenced by methylation.
Control factors continued: • Chromatin conformation (remodelling) • Antirepressors & nucleosome positioning. • Histone acetylation – (acetyl groups on lysines), histone acetyltransferase enzyme catalyzes the addition of lysine, targeted to genes by specific TFs. • Heterochromatin – highly condensed, transcriptionally inert (off).
B. Eukaryotic Promoters Usually located within 100 bp upstream Usually contains TATA box (25 – 30) bases upstream from start point, additional elements: • CAAT box • GC box • Recognized byRNA Pol II (transcribes mRNA) • Require the binding of several protein factors to initiate transcription (DNA binding domains on TFs – ‘motifs’) • May be positively or negatively regulated
C. Transcription Factors –the transcription complex • TFIIA, TFIIB, TFIID, TFIIE, TFIIH • TATA binding protein (TBP) • TBP associated factors (TAFs)
Assembly of the basal transcription apparatus - involves stepwise binding of various transcription factor proteins. • These trans-acting proteins are required for RNA pol II to initiate transcription. • Commitment Stage & Clearance Stage… • Activators are required to bring about normal levels of transcription
Enhancers Cis regulators that interact with regulatory proteins & TFs to increase the efficiency of transcription initiation. Silencers – cis-acting, bound by repressors, or cause the chromatin to condense and become inactive. Activators - Proteins that function by contacting basal transcription factors and stimulating the assembly of pre-initiation complexes at promoters.
D. An example of transcriptional control: Galactose metabolism in yeast • GAL1, GAL7, GAL10 genes… products required for conversion of galactose into glucose Closely linked genes, but monocistronic mRNAs synthesized These are only transcribed when galactose is present…
Controlling GAL GAL80 encodes a protein that negatively regulates transcription. The repressor protein binds to an Activator protein, rendering it inactive. GAL4 encodes an activator w/zinc finger motif that activates transcription of the three GAL genes individually. Galactose = Inducer, that binds to Gal80, causing it to release Gal4 • Although this looks similar to Lac Operon, there are different molecular mechanisms…
Two trans-acting genes (GAL4 and GAL80) and one upstream cis-acting locus (UAS) work to regulate galactokinase synthesis.
III. Post-transcriptional control • Alternative splicing - Some messages undergo alternate splicing depending on what tissue they are located in. The regulation is at the level of snRNP production. • Some pre-mRNAs can be spliced in more than one way, producing 2+ alternative mRNA’s • Can introduce stop codons or change the reading frame • Controlled by RNA binding splicing factors that commit splicing in a particular way
Alternative polyadenylation and splicing of the human CACL gene in thyroid and neuronal cells. Calcitonin gene-related peptide
Post-transcriptional control cont. • The stability of a class of mRNA can be controlled. • Some short-lived mRNAs have multiple copies of the sequence AUUUA which may act as a target for degradation. • the hormone prolactin enhances the stability of the mRNA for the milk protein casein • high levels of iron decrease the stability of the mRNA for the receptor that brings iron into cells • RNA interference – poorly understood, but appears to be widespread in fungi, plants and animals as a regulatory mechanism • miRNAs & siRNAS (small RNA molecules) pair with proteins to form an RNA-induced silencing complex (RISC) • RISC pairs w/complentary base sequences of specific mRNAs and causes: • Cleavage of mRNA • Inhibition of translation • Transcriptional silencing • Degradation of mRNA